Strata Skin Sciences, Inc.
SSKN
$2.59
-$0.03-1.15%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -18.53% | -101.52% | 96.86% | -18.80% | -2,271.25% |
| Total Depreciation and Amortization | -4.16% | -14.17% | -10.87% | -10.52% | -6.67% |
| Total Amortization of Deferred Charges | 39.29% | 34.48% | -7.14% | -24.39% | -31.71% |
| Total Other Non-Cash Items | 43.90% | -108.31% | -90.74% | 52.17% | 716.88% |
| Change in Net Operating Assets | -87.01% | 117.14% | -160.08% | 242.45% | 180.88% |
| Cash from Operations | -48.72% | 85.05% | -37.59% | 1.59% | 665.92% |
| Capital Expenditure | 70.66% | -131.96% | 79.74% | 59.54% | -1.12% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 70.66% | -131.96% | 79.74% | 59.54% | -1.12% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | 100.00% | -- | 100.00% |
| Cash from Financing | -- | 1,968.27% | -100.00% | -- | 100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 157.35% | 181.81% | -96.04% | 40.71% | 82.82% |